NSAM
North Star Asset Management Portfolio holdings
AUM
$2.36B
1-Year Return
14.42%
This Quarter Return
+5.03%
1 Year Return
+14.42%
3 Year Return
+63.82%
5 Year Return
+104.72%
10 Year Return
+249.93%
AUM
$1.17B
AUM Growth
+$53.2M
(+4.8%)
Cap. Flow
+$10.6M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
20.87%
Holding
305
New
11
Increased
89
Reduced
116
Closed
4
Top Buys
| 1 |
Wyndham Hotels & Resorts
WH
|
$9.63M |
| 2 |
Analog Devices
ADI
|
$3.62M |
| 3 |
Meta Platforms (Facebook)
META
|
$3M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$2.26M |
| 5 |
Eaton
ETN
|
$1.85M |
Top Sells
| 1 |
Travel + Leisure Co
TNL
|
$8.56M |
| 2 |
PAY
Verifone Systems Inc
PAY
|
$6.34M |
| 3 |
EPAY
Bottomline Technologies Inc
EPAY
|
$2.99M |
| 4 |
CA
CA, Inc.
CA
|
$1.72M |
| 5 |
Adobe
ADBE
|
$1.69M |
Sector Composition
| 1 | Technology | 19.4% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 11.41% |
| 4 | Industrials | 10.37% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
ConocoPhillips
COP
$120B
| $794K | 0.07% |
11,405
-151
| -1% | -$10.5K |
|
152
McKesson
MCK
$86B
| $790K | 0.07% |
5,920
| – | – |
|
153
ProAssurance
PRA
$1.22B
| $781K | 0.07% |
22,029
| – | – |
|
154
Bristol-Myers Squibb
BMY
$95B
| $763K | 0.07% |
13,787
-175
| -1% | -$9.69K |
|
|
ATVI
155
DELISTED
Activision Blizzard Inc.
ATVI
| $763K | 0.07% |
10,000
| – | – |
|
156
Exelixis
EXEL
$10.1B
| $742K | 0.06% |
34,500
| – | – |
|
157
iShares MSCI EAFE ETF
EFA
$65.9B
| $731K | 0.06% |
10,904
+1,073
| +11% | +$71.9K |
|
158
Merck
MRK
$210B
| $714K | 0.06% |
12,330
-450
| -4% | -$26.1K |
|
159
AT&T
T
$212B
| $711K | 0.06% |
29,309
-2,933
| -9% | -$71.2K |
|
160
Phillips 66
PSX
$53.2B
| $701K | 0.06% |
6,240
| – | – |
|
|
RMT
161
Royce Micro-Cap Trust
RMT
$536M
| $700K | 0.06% |
70,023
-150
| -0.2% | -$1.5K |
|
162
Jabil
JBL
$22.3B
| $699K | 0.06% |
25,280
-325
| -1% | -$8.99K |
|
163
WEC Energy
WEC
$34.6B
| $676K | 0.06% |
10,454
| – | – |
|
164
Vertex Pharmaceuticals
VRTX
$102B
| $671K | 0.06% |
3,950
| – | – |
|
165
Berkshire Hathaway Class B
BRK.B
$1.09T
| $661K | 0.06% |
3,541
| – | – |
|
166
Vanguard Growth ETF
VUG
$187B
| $635K | 0.05% |
4,243
-25
| -0.6% | -$3.74K |
|
167
Ionis Pharmaceuticals
IONS
$9.46B
| $633K | 0.05% |
15,200
| – | – |
|
|
ARRY
168
DELISTED
Array Biopharma Inc
ARRY
| $631K | 0.05% |
37,600
| – | – |
|
169
Norfolk Southern
NSC
$62.8B
| $630K | 0.05% |
4,175
-40
| -0.9% | -$6.04K |
|
170
SEI Investments
SEIC
$11B
| $625K | 0.05% |
9,989
-375
| -4% | -$23.5K |
|
171
Accenture
ACN
$158B
| $622K | 0.05% |
3,800
| – | – |
|
172
W.W. Grainger
GWW
$49.2B
| $617K | 0.05% |
2,000
| – | – |
|
173
Medtronic
MDT
$119B
| $615K | 0.05% |
7,185
-310
| -4% | -$26.5K |
|
174
Fortive
FTV
$16.1B
| $610K | 0.05% |
9,450
+96
| +1% | +$6.2K |
|
175
Boeing
BA
$174B
| $594K | 0.05% |
1,771
| – | – |
|